A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain
- First Posted Date
- 2022-03-28
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Lateral Pharma Pty Ltd
- Target Recruit Count
- 26
- Registration Number
- NCT05298306
- Locations
- π¦πΊ
PARC Clinical Research, Adelaide, South Australia, Australia
A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute Migraine
- First Posted Date
- 2019-11-06
- Last Posted Date
- 2021-04-28
- Lead Sponsor
- Lateral Pharma Pty Ltd
- Target Recruit Count
- 21
- Registration Number
- NCT04153409
- Locations
- π¦πΊ
Paratus Clinical Research, Blacktown, Sydney, New South Wales, Australia
π¦πΊParatus Clinical Research, Central Coast, Kanwal, New South Wales, Australia
π¦πΊEmeritus Research, Camberwell, Victoria, Australia
Oral LAT8881 in Neuropathic Pain
Phase 2
Completed
- Conditions
- Post Herpetic Neuralgia (PHN)Neuropathic PainDiabetic Peripheral Neuropathy (DPN)
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-03-07
- Last Posted Date
- 2021-06-14
- Lead Sponsor
- Lateral Pharma Pty Ltd
- Target Recruit Count
- 53
- Registration Number
- NCT03865953
- Locations
- π¦πΊ
Paratus Clinical Research Blacktown, Sydney, New South Wales, Australia
π¦πΊParatus Clinical Research Kanwal, Kanwal, New South Wales, Australia
π¦πΊAusTrials, Brisbane, Queensland, Australia
Β© Copyright 2025. All Rights Reserved by MedPath